Now that it has become the investment trend du jour, advisers are cautioning clients not to expect to get rich quick on a product that is still illegal at the federal level.
A product design that's more palatable to brokers and a bigger roster of familiar carriers have raised the product profile for brokers.
Impending change benefits State Street's communications exchange-traded fund.
The operations for feeder funds pool client money to invest in hedge funds and private equity.
Universal life insurance lawsuits may cause you to rethink your policy.
Gerber Life has $52 billion of life insurance in force and covers 3.6 million policies for individuals.
Fed moves are among the factors that could put an end to the rally in small caps.
Funds focused on socially responsible investing hold just 0.2% of all ETF assets, but there are steps providers can take to rev up interest.
Flight to quality overlooks the risks to fixed income that come with rising interest rates.
An index of asset managers and custody banks is down almost 11% this year, and some fund companies are off more than 25%.
Ultrawealthy look beyond hedge funds and private equity to making direct investments in businesses.
Fixed annuities are positioned for a record year, with fixed-rate deferred and indexed annuities driving the growth.
Pennsylvania advisory firm invested client funds in expensive share classes when less costly ones were available.
Ultrawealthy look beyond hedge funds and private equity to making direct investments in businesses.
Johnson says way to prosper in financial services is 'by building relationships.'
The nine-year-old bull market is giving some investors the jitters, but the ETF industry is trying to calm their fears.
Rules adopted by 41 states have held down rate increases on newer policies, but some advisers remain skeptical of traditional LTC insurance.
Fund suffered several big swings during the first six months of this year.
One fund will track an index of large-cap companies and the other an index of midsize and small firms.
The firm sells illiquid, high-risk and high-commission alternative investments.
